NCT04968899View on ClinicalTrials.gov

IgIV Plus Prednisone vs High-dose Dexamethasone for ITP

PHASE3RecruitingINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

April 7, 2022

Primary Completion Date

April 9, 2025

Study Completion Date

October 9, 2026

Conditions
Immune Thrombocytopenia (ITP)
Interventions
DRUG

Neofordex®

Oral dexamethasone (Neofordex®) 40 mg (Day1 to Day 4), ± an additional 4-days cycle of dexamethasone between days 10 and 21.

DRUG

Intravenous immunoglobulins

IVIg (1g/kg D1-D2) plus oral prednisone (1 mg/kg/day x 21 days (3 weeks))

Trial Locations (1)

94010

RECRUITING

Henri Mondor Hospital, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER